Your session is about to expire
← Back to Search
HIV Vaccine for HIV Infection (NETI Trial)
NETI Trial Summary
This trial is testing an investigational vaccine to see if it is safe and effective in stimulating the production of broadly neutralizing antibodies against HIV.
NETI Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowNETI Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.NETI Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been treated for hepatitis C within the last 6 months.I have been on consistent HIV medication for at least 2 years without a break longer than 30 days.You have a very high body weight for your height.I have not received any live vaccines in the last 4 weeks.I haven't taken any immune system drugs, chemotherapy, or experimental treatments in the last 60 days.I have not received blood products or immune globulins in the last 16 weeks.You have had a serious allergic reaction or severe response to previous vaccinations.I am currently on a maintenance schedule for my allergy shots.I started HIV treatment within 3 months of my diagnosis.My HIV-1 levels have been under control for at least 2 years with treatment.I have a chronic inflammatory condition like rheumatoid arthritis or lupus.You have allergies or sensitivities to any ingredients in the study vaccine.I haven't been hospitalized or needed serious treatment in the last 30 days.I am older than 18 years.
- Group 1: Randomized Blinded Trimer 4571 Vaccine 100mcg
- Group 2: Randomized Blinded Placebo for Trimer 4571 Vaccine 100mcg
- Group 3: Randomized Blinded Trimer 4571 Vaccine 500mcg
- Group 4: Randomized Blinded Placebo for Trimer 4571 Vaccine 500mcg
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the administration approved Trimer 4571 vaccine 500mcg with 500mcg alum adjuvant?
"Based on the current evidence, our team at Power has assigned Trimer 4571 vaccine 500mcg with 500 mcg alum adjuvant a rating of 1. This reflects that it is currently in Phase 1 clinical trials and there are limited data points evidencing safety or efficacy."
What is the total enrollment figure for this research project?
"Affirmative. Information hosted on clinicaltrials.gov indicates that this study, which was initially published on September 30th 2021, is actively searching for trial participants. Consequently, 32 patients will need to be recruited from two separate medical centres."
Are there any vacancies left for participants in this clinical trial?
"Affirmative. According to the clinicaltrials.gov listing, this investigation is still recruiting participants that it first posted for on September 30th 2021. 32 candidates need to be sourced from 2 different sites."
Share this study with friends
Copy Link
Messenger